Names and pronunciation
(en-trex′tih-nib) Rozlytrek
PDF page 475
Drug reference
(en-trex′tih-nib) Rozlytrek
PDF page 475
Func. class.: Antineoplastic orphan drug
PDF page 475
Chem. class.: Tyrosine kinase ROS1 inhibitor, tropomyosin receptor kinase (TRK) inhibitor
PDF page 475
USES: ROS1-positive non–small-cell lung cancer and NTRK gene fusion– positive solid tumors
PDF page 475
CONTRAINDICATIONS Hypersensitivity, pregnancy, breast- feeding
PDF page 475
DOSAGE AND ROUTES • Adult: PO 600 mg daily until disease progression or unacceptable toxicity
PDF page 475
Available forms: Capsule 100, 200 mg
PDF page 475
• Adult: PO 600 mg daily until disease progression or unacceptable toxicity
PDF page 475